Emerging biomarkers and metabolomics for assessing toxic nephropathy and acute kidney injury (AKI) in neonatology
about
The potential use of biomarkers in predicting contrast-induced acute kidney injurySerial plasma metabolites following hypoxic-ischemic encephalopathy in a nonhuman primate model.The use of urinary and kidney SILAM proteomics to monitor kidney response to high dose morpholino oligonucleotides in the mdx mouse.Predicting acute kidney injury: current status and future challenges.A propensity-matched cohort study of vancomycin-associated nephrotoxicity in neonates.The role of oxidative stress in acute renal injury of newborn rats exposed to hypoxia and endotoxin.
P2860
Emerging biomarkers and metabolomics for assessing toxic nephropathy and acute kidney injury (AKI) in neonatology
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Emerging biomarkers and metabo ...... ey injury (AKI) in neonatology
@ast
Emerging biomarkers and metabo ...... ey injury (AKI) in neonatology
@en
Emerging biomarkers and metabo ...... ey injury (AKI) in neonatology
@nl
type
label
Emerging biomarkers and metabo ...... ey injury (AKI) in neonatology
@ast
Emerging biomarkers and metabo ...... ey injury (AKI) in neonatology
@en
Emerging biomarkers and metabo ...... ey injury (AKI) in neonatology
@nl
prefLabel
Emerging biomarkers and metabo ...... ey injury (AKI) in neonatology
@ast
Emerging biomarkers and metabo ...... ey injury (AKI) in neonatology
@en
Emerging biomarkers and metabo ...... ey injury (AKI) in neonatology
@nl
P2860
P921
P3181
P356
P1476
Emerging biomarkers and metabo ...... ey injury (AKI) in neonatology
@en
P2093
J N Van Den Anker
P2860
P304
P3181
P356
10.1155/2014/602526
P407
P5008
P577
2014-06-11T00:00:00Z